Biostar Pharmaceuticals

(OTC) BSPM

Current Price$0.00

Market CapN/A

Since IPO (2008)-100%

5 Year-100%

1 Year-99%

1 Month+0%

Biostar Pharmaceuticals Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$317.79K

Net Income (TTM)

$935.00K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

2947.40 (High)

Dividend

$0.00

Beta (Volatility)

2947.40 (High)

Price

$0.00

Volume

Open

$0.00

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.05

Dividend

$0.00

Beta (Volatility)

2947.40 (High)

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.05

BSPM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biostar Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Headquarters

Xianyang, 712000, CN

BSPM Financials

Key Financial Metrics (TTM)

Gross Margin

38%

Operating Margin

-1%

Net Income Margin

-2%

Return on Equity

Return on Capital

-10%

Return on Assets

-13%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$0.00

Shares Outstanding

2.64M

Volume

Avg. Volume

8.984

Financials (TTM)

Gross Profit

$915.17K

Operating Income

$3.56M

EBITDA

$1.70M

Operating Cash Flow

$4.91M

Capital Expenditure

$0.00

Free Cash Flow

$4.91M

Cash & ST Invst.

$173.29K

Total Debt

$2.33M

Biostar Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q3 2017YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$0.00

N/A

Market Cap/Employee

N/A

Employees

200

N/A

Net Income

$125.00K

+92.0%

EBITDA

$222.27K

+121.0%

Quarterly Fundamentals

Name

Q3 2017YOY CHG

Net Cash

$2.06M

-17.0%

Accounts Receivable

$461.03K

-92.4%

Inventory

$170.56K

-61.2%

Long Term Debt

$0.00

N/A

Short Term Debt

$2.43M

+0.2%

Return on Assets

-13.41%

N/A

Return on Invested Capital

-9.66%

N/A

Free Cash Flow

$1.41K

-100.3%

Operating Cash Flow

$1.41K

-100.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CWWBFPlant-Based Investment Corp.

CWWBFPlant-Based Investment Corp.$0.00+0.00%

CRFTFBC Craft Supply Co. Ltd.

CRFTFBC Craft Supply Co. Ltd.$0.00+0.00%

PEMTFThoughtful Brands Inc.

PEMTFThoughtful Brands Inc.$0.00+0.00%

BIOCQBiocept, Inc.

BIOCQBiocept, Inc.$0.00+0.00%

CLVRClever Leaves Holdings Inc.

CLVRClever Leaves Holdings Inc.$0.00+0.00%

HTGMQHTG Molecular Diagnostics, Inc.

HTGMQHTG Molecular Diagnostics, Inc.$0.00+0.00%

ELOXEloxx Pharmaceuticals, Inc.

ELOXEloxx Pharmaceuticals, Inc.$0.19+5.56%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About BSPM

What is the current price of Biostar Pharmaceuticals?

Biostar Pharmaceuticals is trading at N/A per share.

What is the 52-week range for Biostar Pharmaceuticals?

Over the past 52 weeks, Biostar Pharmaceuticals has traded between N/A and $0.05.

How much debt does Biostar Pharmaceuticals have?

Biostar Pharmaceuticals total debt is unavailable.

How much cash does Biostar Pharmaceuticals have on hand?

Biostar Pharmaceuticals does not have cash on hand data available.

What is Biostar Pharmaceuticals’s dividend yield?

Biostar Pharmaceuticals does not currently have a dividend yield.

Biostar Pharmaceuticals

Biostar Pharmaceuticals Financials at a Glance

BSPM News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Biostar Pharmaceuticals

BSPM Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Biostar Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BSPM

What is the current price of Biostar Pharmaceuticals?

What is the 52-week range for Biostar Pharmaceuticals?

How much debt does Biostar Pharmaceuticals have?

How much cash does Biostar Pharmaceuticals have on hand?

What is Biostar Pharmaceuticals’s dividend yield?

Premium Investing Services